DK0474789T3 - Peptid med thiol-beskyttet cystein til anvendelse i immnoassays - Google Patents
Peptid med thiol-beskyttet cystein til anvendelse i immnoassaysInfo
- Publication number
- DK0474789T3 DK0474789T3 DK90911054T DK90911054T DK0474789T3 DK 0474789 T3 DK0474789 T3 DK 0474789T3 DK 90911054 T DK90911054 T DK 90911054T DK 90911054 T DK90911054 T DK 90911054T DK 0474789 T3 DK0474789 T3 DK 0474789T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- immunoassays
- thiol
- peptide
- htlv
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title 1
- 235000018417 cysteine Nutrition 0.000 title 1
- 238000003018 immunoassay Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241001430294 unidentified retrovirus Species 0.000 abstract 2
- DJQYYYCQOZMCRC-UHFFFAOYSA-N 2-aminopropane-1,3-dithiol Chemical group SCC(N)CS DJQYYYCQOZMCRC-UHFFFAOYSA-N 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 abstract 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 abstract 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36051389A | 1989-06-02 | 1989-06-02 | |
| PCT/US1990/003148 WO1990015071A1 (en) | 1989-06-02 | 1990-06-04 | Cysteine thiol-protected peptides for use in immunoassays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0474789T3 true DK0474789T3 (da) | 1998-09-28 |
Family
ID=23418295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90911054T DK0474789T3 (da) | 1989-06-02 | 1990-06-04 | Peptid med thiol-beskyttet cystein til anvendelse i immnoassays |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0474789B1 (da) |
| JP (1) | JP3404035B2 (da) |
| KR (1) | KR960013600B1 (da) |
| AT (1) | ATE162799T1 (da) |
| AU (1) | AU652919B2 (da) |
| CA (1) | CA2056381C (da) |
| DE (1) | DE69032009T2 (da) |
| DK (1) | DK0474789T3 (da) |
| ES (1) | ES2113860T3 (da) |
| FI (1) | FI102834B1 (da) |
| NO (1) | NO304151B1 (da) |
| WO (1) | WO1990015071A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083504A (en) * | 1989-08-24 | 2000-07-04 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| US5459060A (en) * | 1989-08-24 | 1995-10-17 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| US6008044A (en) * | 1989-08-24 | 1999-12-28 | Bioclonetics | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC) |
| DE69129207T2 (de) * | 1990-01-16 | 1998-10-08 | Orgenics Ltd | Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS |
| BR0015170A (pt) * | 1999-10-27 | 2002-06-25 | Innogenetics Nv | Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa |
| JP5182069B2 (ja) * | 2008-12-24 | 2013-04-10 | Ｊｎｃ株式会社 | チオール基を有する刺激応答性磁性微粒子及びその利用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111924A (en) * | 1976-01-05 | 1978-09-05 | Takeda Chemical Industries, Ltd. | Method for removal of thiol-protecting groups |
| FR2525592B1 (da) * | 1982-04-26 | 1984-09-14 | Pasteur Institut | |
| US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
| WO1987006005A1 (en) * | 1986-03-24 | 1987-10-08 | Ortho Pharmaceutical Corporation | Synthetic htlv-iii peptides, compositions and uses thereof |
| DE3789633T2 (de) * | 1986-05-27 | 1994-08-04 | Hoffmann La Roche | HTLV-III(LAV)Decke-Peptide. |
| GB8828097D0 (en) * | 1988-12-01 | 1989-01-05 | Wellcome Found | Peptides |
-
1990
- 1990-06-04 DE DE69032009T patent/DE69032009T2/de not_active Expired - Fee Related
- 1990-06-04 ES ES90911054T patent/ES2113860T3/es not_active Expired - Lifetime
- 1990-06-04 JP JP51045090A patent/JP3404035B2/ja not_active Expired - Lifetime
- 1990-06-04 KR KR1019910701744A patent/KR960013600B1/ko not_active IP Right Cessation
- 1990-06-04 EP EP90911054A patent/EP0474789B1/en not_active Expired - Lifetime
- 1990-06-04 AU AU60532/90A patent/AU652919B2/en not_active Expired
- 1990-06-04 DK DK90911054T patent/DK0474789T3/da active
- 1990-06-04 CA CA002056381A patent/CA2056381C/en not_active Expired - Lifetime
- 1990-06-04 WO PCT/US1990/003148 patent/WO1990015071A1/en active IP Right Grant
- 1990-06-04 AT AT90911054T patent/ATE162799T1/de not_active IP Right Cessation
-
1991
- 1991-11-29 NO NO914725A patent/NO304151B1/no not_active IP Right Cessation
- 1991-11-29 FI FI915649A patent/FI102834B1/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI102834B (fi) | 1999-02-26 |
| AU6053290A (en) | 1991-01-07 |
| ES2113860T3 (es) | 1998-05-16 |
| FI102834B1 (fi) | 1999-02-26 |
| DE69032009D1 (de) | 1998-03-05 |
| ATE162799T1 (de) | 1998-02-15 |
| CA2056381A1 (en) | 1990-12-03 |
| JPH04505623A (ja) | 1992-10-01 |
| KR960013600B1 (ko) | 1996-10-09 |
| EP0474789B1 (en) | 1998-01-28 |
| DE69032009T2 (de) | 1998-07-23 |
| JP3404035B2 (ja) | 2003-05-06 |
| NO914725D0 (no) | 1991-11-29 |
| AU652919B2 (en) | 1994-09-15 |
| NO914725L (no) | 1992-01-29 |
| FI915649A0 (fi) | 1991-11-29 |
| KR920701236A (ko) | 1992-08-11 |
| NO304151B1 (no) | 1998-11-02 |
| EP0474789A4 (en) | 1992-06-03 |
| WO1990015071A1 (en) | 1990-12-13 |
| CA2056381C (en) | 2000-08-22 |
| EP0474789A1 (en) | 1992-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO891711L (no) | Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr. | |
| NZ219113A (en) | Hiv peptide containing epitope of the env protein | |
| DE69129803D1 (de) | Wasserlösliche peptidanaloguen mit bindungstellen | |
| BR9106220A (pt) | Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c. | |
| IL134982A0 (en) | Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith | |
| DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
| DK0474789T3 (da) | Peptid med thiol-beskyttet cystein til anvendelse i immnoassays | |
| ES2080047T3 (es) | Peptidos hiv y metodos para la deteccion de hiv. | |
| DE69015708D1 (de) | Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1. | |
| DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
| DK0383599T3 (da) | Protein-anticancermiddel | |
| ES2074591T3 (es) | Expresion de polipeptidos de vih 1 y 2 y su utilizacion. | |
| DE69011122D1 (de) | Rubella-e1 und c peptide. | |
| IL102615A (en) | Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies | |
| DK0550691T3 (da) | Antistofinducerende peptider, som inhiberer retrovira af HIV-typen, og antistoffer, som er specifikke for disse peptider | |
| DK0732339T3 (da) | Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf | |
| GR900100608A (el) | Κυστέϊνο ?ειολο-προστατευμένα πεπτίδια γιά χρήση σε ανοσοδοκιμασίες. | |
| DE69017352D1 (de) | An HIV relatierte Peptide. | |
| DE69012989D1 (de) | Peptiden von retinblastoma gen produkten und antikoerper dagegen. | |
| Blake et al. | Cysteine thiol-protected peptides for use in immunoassays | |
| DK0540560T3 (da) | Ancrod-lignende proteiner, fremstilling og anvendelse deraf | |
| DE69921589D1 (de) | Peptide zum Nachweis von HIV-1-Guppe O | |
| TH62264A (th) | Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv |